A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Advanced Prostate Cancer
Related studies linked through entity extraction aliases.
Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
- Status
- COMPLETED
- Phase
- PHASE3
Whole Body Magnetic Resonance Imaging Study
- Status
- UNKNOWN
- Phase
- N/A
A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
- Status
- TERMINATED
- Phase
- PHASE4
SRAM study_Postate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
TUPKRP Combined With MAB Therapy for LUTS/PCa
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of HPN424 in Patients With Advanced Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.
- Status
- UNKNOWN
- Phase
- N/A
PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide.
- Status
- UNKNOWN
- Phase
- N/A
PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate.
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.
- Status
- UNKNOWN
- Phase
- N/A
Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists.
- Status
- COMPLETED
- Phase
- N/A
Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel
- Status
- WITHDRAWN
- Phase
- PHASE2
A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- N/A
Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE3